In the Pipeline: Top Drug Candidates for FDA Approval in 2024 FDA Removes 14 Peptides from Category 2 to Category 1 Mansi Hukmani posted on the topic LinkedIn The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Approves Iptacopan Oral Monotherapy for PNH Injectable and Topical Peptides in Aesthetic Medicine Mechanisms, Clinical Applications, and Future Potential PRIME Journal Research peptide drugs (e.g., CJC 1295, Ipamorelin, BPC 157) are the newest trend in the fitness space, although they've been popular in the wellness space for quite some time. Despite their popularity, the